Last reviewed · How we verify
Isopropamid (ISOPROPAMIDE)
Isopropamide, also known as ISOPROPAMIDE, is a small molecule drug developed by GlaxoSmithKline that targets the muscarinic acetylcholine receptor M1. It was approved by the FDA in 1957 for the treatment of peptic ulcers. As an off-patent medication, it is no longer protected by active patents, and there are currently no generic manufacturers. Isopropamide works by stimulating the muscarinic receptors in the stomach, which helps to increase the movement of food through the digestive system and reduce stomach acid production. It is a medication that has been used for many years to treat peptic ulcers.
At a glance
| Generic name | ISOPROPAMIDE |
|---|---|
| Sponsor | GSK |
| Drug class | isopropamide |
| Target | Muscarinic acetylcholine receptor M1 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1957 |
Approved indications
- Peptic ulcer
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |